"QUEISSER PHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ"

TAX ID5213787274

KRS0000685744

Share capital2,000,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. DOMANIEWSKA 39, 02-672 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

"QUEISSER PHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ"

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. DOMANIEWSKA 39, 02-672 WARSZAWA

Show on map

NIP

5213787274

REGON

367423839

KRS

0000685744

Legal form

limited liability company

Register Address

UL. DOMANIEWSKA 39, 02-672 WARSZAWA

Date of registration in KRS

2017-07-05

Date of commencement of economic activity

2017-07-05

Act signature

WA.XIII NS-REJ.KRS/16158/22/355/ADE

Pkd codes

73.11.Z - Advertising agency activities

47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products

47.29.Z - Retail trade

63.12.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services

70.21.Z - Head office activities and management consultancy

73.12.A - Advertising through mass media

73.12.B - Advertising through mass media

73.12.C - Advertising through mass media

73.12.D - Advertising through mass media

73.20.Z - Market research and public opinion polling

Company authorities

representation authorityMANAGEMENT

representation type

DO REPREZENTOWANIA SPÓŁKI UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

MANAGEMENT

Renata Maria Kasprzyk

Chairman Of The Board, 54 years old

shareholders

QUEISSER PHARMA GMBH & CO.KG

100% 20000 udziałów o łącznej wartości 2.000.000,00 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Profit (loss) on sale				164 413,9
Gross profit (loss)	2,2	2	2	-0,1
EBITDA	2,2	2,2	1,7	-21,7
Short time liabilities	4,8	5,9	6,8	15,9
Other operating costs				3 283 816,7
Equity capital	5,6	7	6,8	-2,2
Operating profit (EBIT)	2,2	2	1,6	-19,9
Assets	11,9	14,9	15,4	3,1
Net profit (loss)	1,8	1,4	1,6	14,5
Cash	10,6	13,3	13,6	1,8
Net income from sale	30,4	30,7	33,5	9,2
Liabilities and provisions for liabilities	6,3	7,9	8,6	7,7
Working assets	11,4	14,5	15	3,6
Other income costs				368 833,3
Depreciation	0	0,1	0,1	-47,7
	%	%	%	p.p.
Profitability of capital	33	19,9	23,3	3,4
Equity capital to total assets	47,1	46,8	44,4	-2,4
Gross profit margin	7,3	6,4	5,9	-0,5
EBITDA Margin	7,4	7,1	5,1	-2
	Days	Days	Days	Days
Short term commitment turnover cycle	58	70	74	4

Current financial liquidity indicator	1.8643009662628174	1.8698649406433105	1.8200863599777222	-0,1
Net dept to EBITDA	-4.732801914215088	-6.109495162963867	-7.947232723236084	-1,8